BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
44 results:

  • 1. Fibrothecoma of broad ligament with minor sex cord elements: Case report and brief literature review.
    Chen Y; Zhou P; Chen J
    Medicine (Baltimore); 2023 Mar; 102(9):e33127. PubMed ID: 36862914
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recurrence and survival in endometrioid endometrial cancer - a population-based cohort study.
    Åkesson Å; Adok C; Dahm-Kähler P
    Gynecol Oncol; 2023 Jan; 168():127-134. PubMed ID: 36434947
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Overview of familial syndromes with increased skin malignancies.
    Juan HY; Zhou AE; Hoegler KM; Khachemoune A
    Arch Dermatol Res; 2023 May; 315(4):707-727. PubMed ID: 36342513
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Evidence for Epithelial Origin of Mixed ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
    Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
    Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multimodal Treatment of Primary Advanced ovarian cancer.
    Friedrich M; Friedrich D; Kraft C; Rogmans C
    Anticancer Res; 2021 Jul; 41(7):3253-3260. PubMed ID: 34230119
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Collagen XI alpha 1 chain, a potential therapeutic target for cancer.
    Liu Z; Lai J; Jiang H; Ma C; Huang H
    FASEB J; 2021 Jun; 35(6):e21603. PubMed ID: 33999448
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association between sex hormones regulation-related SNP rs12233719 and lung cancer risk among never-smoking Chinese women.
    Qian Y; Xie L; Li L; Feng T; Zhu T; Wang R; Yang Y; Zhou B; Yu H; Qian B
    Cancer Med; 2021 Mar; 10(5):1880-1888. PubMed ID: 33595913
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
    Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
    Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer.
    Rada M; Nallanthighal S; Cha J; Ryan K; Sage J; Eldred C; Ullo M; Orsulic S; Cheon DJ
    Oncogene; 2018 Aug; 37(35):4809-4820. PubMed ID: 29769618
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences.
    Gatius S; Cuevas D; Fernández C; Roman-Canal B; Adamoli V; Piulats JM; Eritja N; Martin-Satue M; Moreno-Bueno G; Matias-Guiu X
    Pathobiology; 2018; 85(1-2):35-40. PubMed ID: 28614814
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent ovarian cancer: A Systematic Literature Review.
    Hotouras A; Desai D; Bhan C; Murphy J; Lampe B; Sugarbaker PH
    Int J Gynecol Cancer; 2016 May; 26(4):661-70. PubMed ID: 26844612
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer.
    Biglia N; Librino A; Ottino MC; Panuccio E; Daniele A; Chahin A
    Int J Gynecol Cancer; 2015 Mar; 25(3):521-5. PubMed ID: 25621410
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma.
    Taube ET; Denkert C; Pietzner K; Dietel M; Sehouli J; Darb-Esfahani S
    Virchows Arch; 2015 Mar; 466(3):333-42. PubMed ID: 25522951
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Primary ovarian carcinosarcoma. Report of eight cases].
    Montalvo-Esquivel G; Chanona-Vilchis JG; Herrera-Gómez A; Meneses-García AA; Isla-Ortiz D
    Ginecol Obstet Mex; 2014 Jul; 82(7):483-9. PubMed ID: 25102674
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab.
    Steffensen KD; Madsen CV; Andersen RF; Waldstrøm M; Adimi P; Jakobsen A
    Eur J Cancer; 2014 Oct; 50(15):2611-8. PubMed ID: 25087181
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of epithelial ovarian cancer.
    Kong D; Shi S; Li Y; Li R; Li M
    Mitochondrial DNA A DNA Mapp Seq Anal; 2016; 27(2):1141-3. PubMed ID: 25028791
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
    Thériault BL; Basavarajappa HD; Lim H; Pajovic S; Gallie BL; Corson TW
    PLoS One; 2014; 9(3):e91540. PubMed ID: 24626475
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
    Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
    BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [ovarian cancer--modern approach to its origin and histogenesis].
    Nowak-Markwitz E; Spaczyński M
    Ginekol Pol; 2012 Jun; 83(6):454-7. PubMed ID: 22880466
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Emergence of CA125 immunoreactivity in recurrent or metastatic primary ovarian mucinous neoplasms of the intestinal type.
    Miller K; Millar J; McCluggage WG
    Am J Surg Pathol; 2011 Sep; 35(9):1331-6. PubMed ID: 21836488
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.